MedTrace Logo

Retrospective Observational Multicenter Study on the Burden of Hospitalized Patients With Respiratory Tract Infection

NCT07691216 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 70000

Last updated 2026-07-08

No results posted yet for this study

Summary

This multicenter retrospective real-world data study will evaluate the burden of respiratory tract infection (RTI)-related hospitalizations in up to 10 Dutch hospitals between 2018 and 2026.

The study aims to quantify:

* Hospitalization rates
* Healthcare resource utilization (LOS, ICU admissions, readmissions)
* Clinical outcomes (including mortality)
* Direct healthcare costs
* Pathogen-specific burden (e.g., RSV, influenza, SARS-CoV-2) Using linked hospital, laboratory, and administrative data, outcomes will be analyzed by age group, comorbidities, pathogen, and respiratory season. The expected cohort size is approximately 60,000-70,000 patients.

The results will provide evidence to support Dutch public health policy, including RSV immunization strategies, healthcare capacity planning, and antimicrobial stewardship.

Conditions

  • Respiratory Tract Infections (RTI)

Interventions

OTHER

Respiratory tract infection hospitalisation

Hospitalisation with a primary or secondary ICD-10 diagnosis of respiratory tract infection (RTI), including infections caused by RSV, influenza, SARS-CoV-2, and other viral or bacterial pathogens, identified through routine administrative and laboratory data.

Sponsors & Collaborators

  • LOGEX

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2026-12-31
Completion
2027-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07691216 on ClinicalTrials.gov